Clinical Trials Directory

Trials / Completed

CompletedNCT02247934

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

Status
Completed
Phase
Study type
Observational
Enrollment
26 (actual)
Sponsor
Gilead Sciences · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The objectives of this qualitative study are to elicit concepts about symptoms that are important to patients with primary sclerosing cholangitis (PSC), as well as the key impacts of symptoms on patients' day-to-day functioning.

Detailed description

In Step I, concept elicitation one-on-one interviews (via telephone or in person) will be conducted. The aims of the concept elicitation interviews are to: 1. Identify the most common symptoms, as well as the most important symptoms, for patients with PSC, and 2. Assess whether these symptoms impact day-to-day functioning An instrument will be developed based on the symptoms reported and in Step II of the study, the performance of the instrument will be assessed with further interviews.

Conditions

Timeline

Start date
2014-10-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2014-09-25
Last updated
2016-02-09

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02247934. Inclusion in this directory is not an endorsement.